Literature DB >> 1983993

Model of kinetic behavior of deoxyglucose in heterogeneous tissues in brain: a reinterpretation of the significance of parameters fitted to homogeneous tissue models.

K Schmidt1, G Mies, L Sokoloff.   

Abstract

Effects of tissue heterogeneity on regional CMRglc (rCMRglc) calculated by use of the deoxyglucose (DG) method at 45 min following the pulse of DG were evaluated in simulation studies. A theoretical model was developed to describe the kinetics of DG uptake and metabolism in heterogeneous brain tissues. Rate constants were fitted to simulation data for mixed tissue and rCMRglc computed on the basis of this tissue heterogeneity model. The results were compared with those obtained by use of the original model of the DG method for homogeneous tissue, both without (3K model) and with (4K model) a term to describe an apparent loss of deoxyglucose-6-phosphate (DG-6-P). As a direct consequence of tissue heterogeneity, the effective rate constant for phosphorylation of DG, k3*, declined with time. To compensate for the time-changing k3*, estimates of the dephosphorylation rate constant, k4*, were artifactually high when the 4K model was used, even though no dephosphorylation of DG-6-P actually occurred. The present study demonstrates that the finding of a significant k4*, at least within 45 min following a pulse of DG, may not represent dephosphorylation at all, but rather the consequence of measuring radioactivity in a heterogeneous tissue and applying a model designed for a homogeneous tissue. Furthermore, the high estimates of k4* resulted in significant overestimation of rCMRglc. When rCMRglc was computed with the conventional single-scan or autoradiographic method at 45 min after a pulse of DG, the 3K and tissue heterogeneity models yielded values that were within 5% of the true weighted average value for the heterogeneous tissue as a whole. We conclude that the effects of tissue heterogeneity alone can give the appearance of product loss, even when none occurs, and that the use of the 4K model with the assumption of product loss in the 45-min experimental period recommended for the DG method may lead to overestimation of the rates of glucose utilization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1983993     DOI: 10.1038/jcbfm.1991.2

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  13 in total

1.  Wavelet denoising for voxel-based compartmental analysis of peripheral benzodiazepine receptors with (18)F-FEDAA1106.

Authors:  Miho Shidahara; Yoko Ikoma; Chie Seki; Yota Fujimura; Mika Naganawa; Hiroshi Ito; Tetsuya Suhara; Iwao Kanno; Yuichi Kimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11-20       Impact factor: 9.236

2.  Effect of tissue heterogeneity on quantification in positron emission tomography.

Authors:  G Blomqvist; A A Lammertsma; B Mazoyer; K Wienhard
Journal:  Eur J Nucl Med       Date:  1995-07

Review 3.  Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?

Authors:  C S Brock; S R Meikle; P Price
Journal:  Eur J Nucl Med       Date:  1997-06

4.  Cortical activity during olfactory stimulation in multiple chemical sensitivity: a (18)F-FDG PET/CT study.

Authors:  Agostino Chiaravalloti; Marco Pagani; Alessandro Micarelli; Barbara Di Pietro; Giuseppe Genovesi; Marco Alessandrini; Orazio Schillaci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-18       Impact factor: 9.236

5.  Non-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time-activity curves.

Authors:  M Reimold; W Mueller-Schauenburg; G A Becker; G Reischl; B M Dohmen; R Bares
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-19       Impact factor: 9.236

6.  Quantification of cerebral glucose metabolic rate in mice using 18F-FDG and small-animal PET.

Authors:  Amy S Yu; Hong-Dun Lin; Sung-Cheng Huang; Michael E Phelps; Hsiao-Ming Wu
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

7.  Regional rates of cerebral protein synthesis measured with L-[1-11C]leucine and PET in conscious, young adult men: normal values, variability, and reproducibility.

Authors:  Shrinivas Bishu; Kathleen C Schmidt; Thomas Burlin; Michael Channing; Shielah Conant; Tianjiang Huang; Zhong-hua Liu; Mei Qin; Aaron Unterman; Zengyan Xia; Alan Zametkin; Peter Herscovitch; Carolyn B Smith
Journal:  J Cereb Blood Flow Metab       Date:  2008-05-21       Impact factor: 6.200

8.  Propofol anesthesia does not alter regional rates of cerebral protein synthesis measured with L-[1-(11)C]leucine and PET in healthy male subjects.

Authors:  Shrinivas Bishu; Kathleen C Schmidt; Thomas V Burlin; Michael A Channing; Lisa Horowitz; Tianjiang Huang; Zhong-hua Liu; Mei Qin; B-K Vuong; Aaron J Unterman; Zengyan Xia; Alan Zametkin; Peter Herscovitch; Zenaide Quezado; Carolyn B Smith
Journal:  J Cereb Blood Flow Metab       Date:  2009-02-18       Impact factor: 6.200

9.  Voxel-based estimation of kinetic model parameters of the L-[1-(11)C]leucine PET method for determination of regional rates of cerebral protein synthesis: validation and comparison with region-of-interest-based methods.

Authors:  Giampaolo Tomasi; Alessandra Bertoldo; Shrinivas Bishu; Aaron Unterman; Carolyn Beebe Smith; Kathleen C Schmidt
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-13       Impact factor: 6.200

10.  Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET.

Authors:  Nicolas A Karakatsanis; Yun Zhou; Martin A Lodge; Michael E Casey; Richard L Wahl; Habib Zaidi; Arman Rahmim
Journal:  Phys Med Biol       Date:  2015-10-28       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.